Myopia is the most common ocular disorder, today [1], and by 2050, it is predicted that at least half of the world's population will be myopic, with 10% highly myopic [2]. This is a serious problem, and we must try to retard the progression of myopia amongst children. According to Brennan (3), if one reduces the progression of myopia by one third, the result will be a reduction of 73% of myopia over- -5 Dioptres.

References

1. Yam JC., et al. “Low- Concentration Atropine for Myopia Progression (LAMP) Study. A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control”. Ophthalmology (2018): 1-12.
2. Holden BA. “Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050”. Ophthalmology 123.5 (2016): 1036-1042.
3. Brennan NA. “Predicted reduction in high myopia for various degrees of myopia control”. Contact Lens and Anterior Eye 35.1 (2012): e14-e15.
4. Yam JC., et al. “Low-Concentration Atropine for Myopia Progression (LAMP) Study”. Ophthalmology (2018). 
5. Cheng D., et al. “Randomized trial of effect of bifocal and prismatic bifocal spectacles on myopic progression: a two-year study”. Arch Ophthalmology 128 (2010):12-19.
6. Cho P., et al. “The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control”. Current Eye Research 30 (2005): 71-80.
7. Hiroka T., et al. “Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study”. Investigative Ophthalmology and Visual Science 53.7 (2012): 3913-3919.
8. Zhu Q., et al. “Retardation of Myopia Progression by Multifocal Soft Contact Lenses”. International Journal of Medical Sciences 16 (2019): 198-202.
9. Chamberlain P., et al. “A 3-Year Randomized Clinical Trial of Mi Sight Lenses for Myopia Control”. Optometry and Vision Science 96.8 (2019): 556-567.

Citation

Citation: David Berkow. “Myopia Control-Play Your Role”. Acta Scientific Ophthalmology 3.2 (2020): 25-26.

Copyright

Copyright: © 2020 David Berkow. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.